Brainstorm Cell Therapeutics Inc. (BCLI) has seen some recent movement in the marketplace and its stock finished trading at $17.55 yesterday. Investors are starting to take interest of BCLI as the stock traded as high as $17.95 and as low as $17.06 in the prior market trading day.
Brainstorm Cell Therapeutics Inc. (BCLI) average trading volume is 520.41K. However, in the prior market trading day Brainstorm Cell Therapeutics Inc. (BCLI) exchanged 336,307 shares. The First downside support level on BCLI is $16.19 and the First resistance level on BCLI is $17.59. BCLI fifty day moving average is $14.34 and BCLI 200day moving average is $10.59.
Brainstorm Cell Therapeutics Inc. (BCLI) recent performance has been indicated by the recent movement in BCLI stock. BCLI has performed 27.54% over the past 4 weeks, BCLI has performed 36.90% over the past quarter and BCLI has shown 355.84% over the past 1 year. Brainstorm Cell Therapeutics Inc. (BCLI) has a 52 week range of $3.58 to $17.95. Brainstorm Cell Therapeutics Inc. (BCLI) is trading 390.22% from its 52 week low and -2.23% from its 52 week high. Brainstorm Cell Therapeutics Inc. (BCLI) is indicating a 15.24% short float indicating the amount short in the float.
BCLI has 29.27M shares outstanding and 25.16M shares in the float. Brainstorm Cell Therapeutics Inc. (BCLI) currently has a market cap of $558.97M and income of -28.80M. The EPS next quarter for BCLI is -0.26 and forecasted EPS next year is 39.10%. The market cap of Brainstorm Cell Therapeutics Inc. (BCLI) at $558.97M represents how many Investors own shares of BCLI and is based off the last price ($17.55) of BCLI and the amount of shares outstanding (29.27M) with Brainstorm Cell Therapeutics Inc. (BCLI).
Brainstorm Cell Therapeutics Inc. (BCLI) has total cash (mrq) of 16.19M, total cash per share (mrq) of 0.51, total debt of BCLI is at 1.78M and total debt/equity (mrq) is 18.15. . Brainstorm Cell Therapeutics Inc. (BCLI) operating cash flow (ttm) is -27.59M, BCLI leveraged free cash flow (ttm) is -17.41M.
BCLI is trading 13.14% above (bullish) its SMA20, 25.43% above (bullish) its SMA50 and 96.93% above (bullish) its SMA200.
